About The Conference
The National Pharmacy R&D Conference is a triennial event organised by the Pharmaceutical Services Programme (PSP), Ministry of Health (MOH) since 2002 (it was a biennial event until 2018). The conference provides a platform for pharmacy and healthcare personnel to share research findings and expand their research networks.
This year, the 12th National Pharmacy R&D Conference 2024 (12NPRnDC) will be organised by the PSP, MOH in in collaboration the Malaysian Pharmacists Society (MPS) on 19–21 August 2024 in KSL Esplanade Hotel, Klang, Selangor. The theme of this conference is "Unity for Medicine Security: Collaborative Solutions for a Safer Future". In line with the theme, the main objective of the conference is to share research findings pertaining to medicines and vaccines in Malaysia, encompassing a broad area from drug and vaccine development, to access to medicines and pharmaceutical care for patients and consumers.
The 12NPRnDC is expecting around 500 participants. In addition to the pharmacists and health professionals from the public and private healthcare sectors, we will be welcoming a diverse set of participants from the academia, research institutes, industry and government agencies such as the MOSTI, MIDA and MITI. Therefore, the conference will serve as a networking platform to foster more future collaborations and cross-sector partnerships among all stakeholders involved throughout the pharmaceutical product lifecycle within the country and even the ASEAN region. It is hoped that we can capitalise on the power of collaboration in shaping a resilient pharmaceutical ecosystem to enhance the medicines security in Malaysia.
In addition to the highly competitive scientific presentations, we are organising an exhibition for research, pharmaceutical, and health-related companies and agencies to showcase their technologies, new products, new findings and services. Not to be missed are the highly expected Medicine Security Forum, where our knowledgeable panellists will be diving into the issues surrounding medicine security along the pharmaceutical product lifecycle from multiple angles.
Theme
"Unity for Medicine Security: Collaborative Solutions for a Safer Future"
The theme defines a collective and cooperative approach aimed at bolstering the security of medicine to ensure a safer tomorrow. This theme emphasizes the necessity of unity among diverse stakeholders, including healthcare professionals, regulatory agencies, technology experts, and the public, in addressing the complex challenges posed by threats to medicine security.
Key components of this theme include:
Medicine Security: Sustainable and uninterrupted access to efficacious, safe and high-quality medicines used for health promotion, prevention, treatment, rehabilitation and palliative care purposes at all times and during public health emergency.
Collaborative Engagement: Encouraging active participation and collaboration among stakeholders to pool resources, expertise, and insights towards enhancing medicine security.
Innovative Solutions: Promoting the development and implementation of innovative solutions through collaborative efforts, leveraging technology, research, and best practices.
Cross-Sector Partnerships: Recognising the importance of partnerships across various sectors, including healthcare, industry, trade, technology, government and academia, to effectively overcome medicine security challenges.
Shared Responsibility: Highlighting the shared responsibility of all stakeholders in safeguarding medicine security and ensuring the integrity of healthcare systems.
Long-Term Vision: Emphasizing a forward-thinking and proactive approach to address evolving threats and vulnerabilities, with a focus on creating sustainable solutions for a safer future.
Overall, "Unity for Medicine Security: Collaborative Solutions for a Safer Future" underscores the power of collaboration in shaping a resilient healthcare ecosystem that prioritises patient safety, data integrity, and equitable access to medicine.
Conference Highlights
Research Area | ||
---|---|---|
Drug Discovery & Development | Authorisation & Access of Medicine | Pharmaceutical Care |
New Drug Discovery | Market access | Pharmacotherapy |
Pre-clinical | Legislation | Pharmacy Services |
Clinical Trial | Regulatory | Consumerism |
Forum Highlights
Forum I
Local R&D in ensuring medicine security in Malaysia
- Knowledge keepers & scholars roadmap: Learning institutions’ roles towards medicine security successfulness in Malaysia
- Vital roles of research for sustainability of medicines security in Malaysia – the perspective of Ministry of Health (MOH)
- Vital roles of research for sustainability of medicines security in Malaysia – the perspective of Ministry of Science, Technology & Innovation (MOSTI)
- Clinical research for medicines security in Malaysia
Synopsis:
Local R&D is pivotal in safeguarding Malaysia’s interest in medicine security as it actively contributes to crafting safe, efficacious and high-quality medicines tailored to the needs of the population. Commitment for investment in local R&D represents a significant chance for Malaysia to strengthen its healthcare system, improve access to medicines, and stimulate economic growth. Nevertheless, there are several key elements that must be addressed to foster an enabling environment for local R&D. The speakers will enlighten us on the coordination and strategic alignment by the brains of the nation in ensuring medicine security at national level.
Forum II
Pharmaceutical industries spearheading medicine security in Malaysia
- Pharmaceutical supply chain resilience in Malaysia
- Strategic investments in fuelling our pharmaceutical ecosystem
- Empowering local pharmaceutical manufacturers in safeguarding medicine security in Malaysia
- Enhancing access to innovative medicine in Malaysia
Synopsis:
The healthcare system has been significantly challenged by the COVID-19 pandemic, bringing the spotlight onto our pharmaceutical industries and medicine supply chain. In this session, audience will be informed that achieving medicine security necessitates not only self-reliance but also maintaining sustainability in the pharmaceutical ecosystem, in which collaborative efforts and contributions from various stakeholders are integral.
Forum III
Harnessing regional platform to unlock our potential: Learning from ASEAN
- Regional efforts towards medicine and vaccine security and resilience
- Unveiling the resilience of pharmaceutical ecosystem in Indonesia
- The journey of vaccine development in Thailand
Synopsis:
ASEAN member states face varying challenges in medicine security such as limited access to essential medicine, substandard and falsification of medicines and regulatory differences. Leveraging the ASEAN platform provides a strategic approach to enhancing regional health resilience and benefitting the population. Drawing from the experience of other ASEAN countries, Malaysia can fortify its endeavours in medicine security and elevate the health outcomes of its population.
Forum IV
Unity for medicine security: Collaborative solutions for a safer future
- Overview surrounding medicine security
- National Vaccine Development Roadmap: Have we attained self-sufficiency?
- The importance of pharmaceutical resilience for national health reform
Synopsis:
Achieving medicine and health security requires resilience and sustainability. Acknowledging and investing in the resilience of the pharmaceutical sector is critical for building a sustainable and resilient healthcare system that can effectively address the evolving health challenges. Are our existing efforts able to quench the thirst for a safer future? In this final forum session, speakers will open our eyes on how we can possibly level up the collaborative and unified efforts among various key players to bolster medicine security and guarantee a safer future for all.
Tentative Programme
19 August 2024 (Day 1) | |
---|---|
Time | Programme |
09:00 – 09:15 | Welcoming Remarks By the Chairperson of Organising Committee |
09:15 – 10:30 | Forum I
|
10:30 – 11:00 | Coffee Break |
11:00 – 12:00 | Keynote Address Prescription for progress: charting the path forward for medicine security in Malaysia |
12:00 – 12:30 | Educational Symposium I |
12:30 – 13:00 | Educational Symposium II |
13:00 – 14:30 | Lunch Break |
14:30 – 15:30 | Opening Ceremony
|
15:30 – 16:00 | Tea Break |
16:00 – 18:00 | Oral Presentation Poster Viewing Track I: Drug Discovery & Development Track II: Authorisation & Access to Medicine Track III: Pharmaceutical Care |
18:00 | Adjourn |
20 August 2024 (Day 2) | |
---|---|
Time | Programme |
09:00 – 10:15 | Forum II Pharmaceutical industries spearheading medicine security in Malaysia
|
10:15 – 10:45 | Educational Symposium III |
10:45 – 11:15 | Coffee Break |
11:15 – 12:30 | Forum III Harnessing regional platform to unlock our potential: Learning from ASEAN
|
12:30 – 13:00 | Educational Symposium IV |
13:00 – 14:00 | Lunch Break |
14:00 – 18:00 | Oral Presentation Poster Viewing Track I: Drug Discovery & Development Track II: Authorisation & Access to Medicine Track III: Pharmaceutical Care |
18:00 | Tea Break & Adjourn |
21 August 2024 (Day 3) | |
---|---|
Time | Programme |
09:00 – 10:30 | Forum IV Unity for medicine security: Collaborative solutions for a safer future
|
10:30 – 11:00 | Coffee Break |
11:00 – 12:30 | Closing Ceremony
|
12:30 – 14:00 | Lunch End of Conference |
Past Events
Conference Theme | Date & Venue | |
---|---|---|
11th | Pharmacy Research Towards Optimisation of Therapy and Service Delivery | 27th – 30th September 2021, Virtual and FB streaming |
10th | Enhancing Access to Medicines through Value-based Approaches | 9th – 11th July 2018, Royale Chulan Hotel, Seremban |
9th | Cross-disciplinary Research: Fostering Holistic Approach | 8th – 10th August 2016, Hotel Everly, Putrajaya |
8th | Quality R&D: Transforming Universal Excellence | 10th -12th June 2014, Grand Blue Wave Hotel, Shah Alam |
7th | Pharmacy Research: New Frontiers towards the Nation’s Needs | 19th – 21st June 2012, The Zon Regency Hotel, Johor Bahru |
6th | Translating Research into Practice and Policy – The Way Forward | 14th- 16th June 2010, Bayview Hotel, Georgetown, Penang |
5th | Research For Evidences: Strategy to Enhance Medication Safety | 28th – 30th July 2008, Putrajaya Hospital, Putrajaya |
4th | Enhancing Drug Utilization: An Approach towards Quality Use of Medicine | 28th – 30th November 2006, Legacy Hotel, Melaka |
3rd | Quality Improvement through R&D | 5th – 8th September 2004, Pan Pacific Hotel, Sepang, Selangor |
2nd | Perkembangan R&D Farmasi: Isu dan Cabaran | 22nd – 23rd September 2003, Holiday Villa, Langkawi, Kedah |
1st | Penerapan Budaya Penyelidikan Dalam Perkhidmatan Farmasi | 5th – 7th August 2002, New Pacific Hotel, Kota Bahru, Kelantan |
Contact Us
Conference secretariat | rndfarmasi@moh.gov.my |
Pn Siti Nur Su'aidah Nasarudin | Tel: +603-7841 3394 |
Ms Tan Yi Huan | Tel: +603-7841 3658 |
Dr Hafidza Baharom | Tel: +603-7841 3604 |
Ms Chan Pui Lim | Tel: +603-7841 3339 |
Ms Ho See Wan | Tel: +603-7841 3217 |
Monday - Thursday | 8.00 am – 1.00 pm | 2.00 pm – 5.00 pm |
Friday | 8.00 am – 12.15 pm | 2.45 pm – 5.00 pm |
Address: |
KSL Esplanade Hotel |
|
Map: | Map | |
How to get there? | Waze/Maps: KSL Esplanade Hotel Klang Public Transport: MRT & KLIA transit (Station: Putrajaya Sentral) Taking public transport or Grab is recommended |
|
Parking: | Plenty of parking spaces available at a maximum rate of RM5 per day |